|LETTERS TO THE EDITOR
|Year : 2018 | Volume
| Issue : 3 | Page : 437-439
CD4 Count, magnetic resonance-white matter signals, and magnetic resonance spectroscopy in human immunodeficiency virus patients
MA Hashmi1, Shyam Baboo2, Bibhuti Saha3
1 Medical College and Hospitals Campus, MRI Section, Muzaffarpur, Bihar, India
2 Department of Radiology, SKMCH, Muzaffarpur, Bihar, India
3 Department of Medicine, School of Tropical Medicine, Kolkata, West Bengal, India
|Date of Web Publication||6-Jul-2018|
M A Hashmi
Mri-Section, EKO Diagnostics Medical College and Hospitals Campus, 88 College St., Kolkata - 700 073, West Bengal
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Hashmi M A, Baboo S, Saha B. CD4 Count, magnetic resonance-white matter signals, and magnetic resonance spectroscopy in human immunodeficiency virus patients. J Neurosci Rural Pract 2018;9:437-9
|How to cite this URL:|
Hashmi M A, Baboo S, Saha B. CD4 Count, magnetic resonance-white matter signals, and magnetic resonance spectroscopy in human immunodeficiency virus patients. J Neurosci Rural Pract [serial online] 2018 [cited 2018 Oct 23];9:437-9. Available from: http://www.ruralneuropractice.com/text.asp?2018/9/3/437/236013
Human deficiency virus (HIV) causes acquired immune deficiency syndrome (AIDS). The immune system of the body is vulnerable to attack by this virus and leads to multiple focal and diffuse lesions. Reduction in CD4 cells is seen. CD4 cells are type of immune cells, and they are also called “T-cells” or “helper cells.” Centers for Disease Control and Prevention define a person having AIDS if they have a CD4 count below 200, with or without any opportunistic infections or cancers. Patients were mainly from School of tropical Medicine the largest tertiary center in eastern India, and from Medical College and Hospitals. Altogether 32 patients who were seropositive for HIV were examined in our center. Detailed history covering all relevant points including CD4 count and CD4% was recorded. Magnetic resonance (MR) spectroscopy study was done in all patients putting the voxel in white matter area. The study was done at 1.5 Tesla GE Signa, and the results were compiled and data analyzed.
The data were accumulated in a tabular form as shown in [Table 1] and [Table 2]. The majority of the patients were males about, and they were about 67.75% of the total population. Most of the patients were in the age group of 20–40 years and they comprised 93.75% of our study group. Twenty-four patients had CD4 count <200 cells/mm 3. Eight patients had CD4 count above 200 cells/mm 3. CD4% below 5% was seen in 9 patients comprising about 28.0%. CD4% between 5% and 10% was seen in 10 patients comprising about 31.25%. Six patients had CD4% between 20% and 40%. White matter changes were seen in 18 patients comprising about 56% of the study population as shown in [Figure 1]. MR Spectroscopy showing choline peaks which was seen in 16 patients [voxel placed as seen in [Figure 2] and [Figure 3] is showing choline peaks] who were having white matter changes and comprised about 89% of them. The finding was that absolute risk of having white matter lesions in AIDs patient was 56.25%. Absolute Risk of choline peaks in patients with white matter lesions was 89.20%. Absolute risk of choline peaks in patients with CD4 Count below 200 was 58.33%.
|Table 1: Number of persons with CD4 count less and more than 200/mm3 and with choline peaks|
Click here to view
|Figure 1: T2 fluid-attenuated inversion recovery images are showing small white matter hyperintensities in the right subcortical parietal region and in periventricular region|
Click here to view
|Figure 2: Magnetic resonance spectroscopy done in posterior periventricular lesion|
Click here to view
|Figure 3: Magnetic resonance spectroscopy showed increase in choline peaks at that level|
Click here to view
HIV infection leads to multiple and diffuse lesions in the brain. Noninfective and nonmitotic focal lesions can also be small or diffuse white matter changes. CD4 cells are type of white cells that fight infection. CD4 cells move throughout the body destroying germ cells such as bacteria and viruses. A normal CD4 count is from 500 to 1500 cells cubic millimeter. Some patients can have CD4 countless but not so severe infections while the reverse can also be seen. CD4% or the rate of its change is a better predictor of clinical progression. Although the CD4+ absolute number that identifies a specific level of immune suppression changes with age, the CD4+ percentage that defines each immunologic category does not. Thus, a change in CD4+ percentage, not number, may be a better marker to identify disease progression. HIV infects and destroys CD + T Lymphocytes.
HIV encephalopathy leads to myelin pallor leading to hyperintense signal changes as seen in T2 weighted imaging. These lesions do not enhance. They do not have any mass effect. Increase in these lesions is seen as the patient condition deteriorates or CD4 or CD4% decreases. MR Spectroscopy is showing increase in choline peaks  and choline/creatine ratio., Choline which resonates at 3.2 ppm is basically phosphatidylcholine and is a membrane constituent. and is a marker of white matter lesions., The study shows a correlation between CD4 count, white matter changes and choline peaks in MR Spectroscopy. Choline peaks are seen in about 89% of patients with white matter changes, which is a significant value. White matter changes are there CD4 count and CD% decreases. Significant increases in the choline/creatine ratios were seen in patients with low CD4 count. The advantage of this study is that it will help in monitoring the treatment and cliniconeurological and radiological findings in HIV patient. By having CD4 count possibility of white matter changes and its associated importance can be known.
We would like to thank all the staff that has greatly supported me in this project.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Yu LM, Philippa J. Easterbrook, tom marshall. Int J Epidemiol 1997;26:1367-72.
Khilnani P, Rajdev SK, Uttam R. Pediatric aids – Part 1. Indian J Crit Care Med 2003;7:257-72. [Full text]
Kannangai R, Kandathil AJ, Ebenezer DL, Nithyanandam G, Samuel P, Abraham OC, et al.
Evidence for lower CD4+T cell and higher viral load in asymptomatic HIV-1 infected individuals of India: Implications for therapy initiation. Indian J Med Microbiol 2008;26:217-21.
] [Full text]
Elston JW, Thaker HK. Co-infection with human immunodeficiency virus and tuberculosis. Indian J Dermatol Venerol Leprol 2008;74:194-9.
Hurley RA, Ernst T, Khalili K, Del Valle L, Simone IL, Taber KH, et al.
Identification of HIV-associated progressive multifocal leukoencephalopathy: Magnetic resonance imaging and spectroscopy. J Neuropsychiatry Clin Neurosci 2003;15:1-6.
Jarvik JG, Lenkinski RE, Grossman RI, Gomori JM, Schnall MD, Frank I, et al.
Proton MR spectroscopy of HIV-infected patients: Characterization of abnormalities with imaging and clinical correlation. Radiology 1993;186:739-44.
Simone IL, Federico F, Tortorella C, Andreula CF, Zimatore GB, Giannini P, et al.
Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry 1998;64:516-23.
Offiah CE, Turnbull IW. The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients. Clin Radiol 2006;61:393-401.
Chong WK, Sweeney B, Wilkinson ID, Paley M, Hall-Craggs MA, Kendall BE, et al.
Proton spectroscopy of the brain in HIV infection: Correlation with clinical, immunologic, and MR imaging findings. Radiology 1993;188:119-24.
Paul RH, Yiannoutsos CT, Miller EN, Chang L, Marra CM, Schifitto G, et al.
Proton MRS and neuropsychological correlates in AIDS dementia complex: Evidence of subcortical specificity. J Neuropsychiatry Clin Neurosci 2007;19:283-92.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2]